A study to Evaluate Effectiveness of Aromatherapy on selected adverse effects

among patients undergoing Chemotherapy at Cancer Centre in Madurai. by Dhanapriya, G
A STUDY TO EVALUATE EFFECTIVENESS OF 
AROMATHERAPY ON SELECTED ADVERSE EFFECTS 
AMONG PATIENTS UNDERGOING CHEMOTHERAPY AT 
CANCER CENTRE IN MADURAI. 
 
 
 
 
A DISSERTATION SUBMITTED TO 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY, CHENNAI, 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF 
MASTER OF SCIENCE IN NURSING. 
 
APRIL – 2012 
ACKNOWLEDGEMENT 
“When a person doesn’t have gratitude, Something is missing in his or her humanity; 
A person can almost be defined by his or her attitude towards gratitude; 
                                                                                                                      Elie Wisel.                          
The satisfaction and pleasure that accompany the successful completion of any 
task would be incomplete without mentioning the people who have made it possible 
and whose constant guidance and encouragement reward any effort with successfully. 
I consider it is privilege to express my gratitude and respect to all those who have 
guided and  inspired me in the completion of this study. While my are few ; my 
appreciations are unmeasured. 
 
I raise my heart in gratitude to Almighty God who has been the guiding force 
behind all my efforts .  
 
I am grateful to Prof..Dr(Mrs).C.Jothi Sophia,Principal,for extending her 
support to conduct this study. 
 
          I would like to express my sincere gratitude to Prof.(Mrs).Merlin jeyapal, 
M.Sc(N)., RN.RM., Ph.D, Vice Principal, for constant support to this study. 
 
         I express my deep sense of gratitude to Prof.(Mrs).G.Jaya Thanga selvi, 
M.Sc(N), RN.RM, Ph.D, HOD, Medical Surgical Department, C.S.I. Jeyaraj 
Annapackiam College of Nursing, for the moving spirit behind this academic work 
,innovative and constructive guidance ,with very valuable suggestions  and continuous 
to me ,which made this study a meaningful one.  
 
        I express my sincere thanks to Mrs.Anbu Roselin, M.Sc (N)., Mrs.Jeya Jothi, 
M.Sc(N)., and MS.Sobia Gnana Mary M.Sc(N), Lecturer of  C.S.I Jeyaraj 
Annapackiam college of Nursing, for their individual guidance and valuable 
suggestions to conduct this study. 
 
       I would like to express my special thanks to Prof. Mrs.Shanthi M.Sc(N)., 
RN.RM, Ph.D, Professor, C.S.I Jeyaraj Annapackiam college of Nursing, for her 
valuable suggestions to conduct this study. 
        I would like to express my special thanks to Prof. Mrs. Jancy Racheal, 
M.Sc(N)., RN.RM., Ph.D, C.S.I Jeyaraj Annapackiam  college of Nursing, for her 
valuable suggestions and guidance of this study. 
 
        I would like to express my grateful thanks to Mr.Mani, M.Sc., M.Phil., 
Statistician for this excellent advice and support in analyzing the data. 
 
        I am also grateful to Mrs.Angelin Mannova, BLIS., Librarian, CSI Jeyaraj 
Annapackiam College of Nursing ,for the help in availing the library facility. 
 
       I submit my extreme gratefulness to Dr.Balamurugan, M.B.B.S, M.S(ONC) 
Medical director ,Guru Cancer Centre ,Madurai, to conduct this study in their 
esteemed institution. 
 
        At this juncture, I would like to disclose the measureless, pains taking, strength, 
security, funding, encouragement, unconditional love, and complete support by my 
husband Mr. R. Balamurugan during this study. 
 
        I thank my beloved daughter Baby Tharunikhaa Shree for her comprehension 
during the separation. 
 
        I would like to spare a word of a word  thanks to my beloved parents                        
Mr. S. Gnanendran and Mrs. Amshalakshmi ,brother Mr.G.Surendra kumar B.E, 
M.E., and my in-laws Mr.Rajaram and Mrs. Amsha rani who had encouraged me 
in all doings to finish this study efficiently. 
 
       My heartfelt thanks to all my class mates Glittering Gladiolus for all the 
benefits, which I have derived from their positive interaction and goodwill. 
 
       I humbly acknowledge my sincere gratitude and appreciation to all who have 
directly and indirectly contributed to this study.                         
    
 
 
 
 
ABSTRACT 
Introduction 
            Aromatherapy is promoted as a natural way to help patients cope with stress, 
chronic pain, nausea, and depression and to produce a feeling of well being. 
 
Statement of the Problem  
             A study to evaluate the effectiveness of aromatherapy on  selected adverse 
effects among patients undergoing chemotherapy at cancer centre in Madurai. 
 
Objectives  
1. To assess the adverse effects of Chemotherapy before aromatherapy 
among control group and experimental group. 
2. To assess the adverse effects of Chemotherapy after aromatherapy   among 
control group and experimental group. 
3. To find out the effectiveness of aromatherapy on adverse effects   among 
patients on chemotherapy. 
4. To find out the association between aromatherapy and selected  
demographic     variables. 
 
Review of literature 
            A review was done on cancer, chemotherapy effects ,aromatherapy and 
aromatherapy      on reducing chemotherapy adverse effects. 
 
Conceptual Framework 
            The conceptual frame work for this study was based on nursing process 
model-Orlando (1958). 
 
Methodology  
Research design 
         The research design selected for this study was a quasi experimental method. 
Research setting  
         The study was done at Guru cancer centre at Madurai. 
 
 
Sample size 
         The selected adverse effects of chemotherapy patients before and after 
aromatherapy was studied among 60 patients undergoing chemotherapy. In  
experimental group 30 patients and in control group 30 patients. The rating scale were 
used to assess the adverse effects of chemotherapy for data collection  which was 
validated by the experts.  
 
Sampling technique 
           The purposive sampling technique was used. 
Procedure technique 
             In experimental group inhalation of lavender oil mixing with 500ml of boiled 
water for duration of 15-20minutes for 5 days. 
 
Findings 
            In the experimental group the obtained Paired ‘t’ value for adverse effects is 
13.00** which is significant.  
 
Conclusion 
It is inferred that the aromatherapy is effective in reducing chemotherapy 
adverse effects among patients with cancer. Based on the study findings 
recommendations and implications were given.      
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APPENDIX - V 
 
APPENDIX - VI 
PART-I 
A.  DEMOGRAPHIC DATA 
I assure that your answer and response will be kept strictly confidential. 
Investigated will mark your information from the respondents in the given space. 
1. Age in years 
a. 21-30        
b. 31-40        
c. 41-50        
d. 50 and above       
2. Sex 
a. Male        
b. Female        
3. Education 
a. Educated        
b .uneducated        
4. Occupation  
a . Private employee       
b. Government employee      
c. Business        
d. Retired        
e. Coolie        
f. Others        
5. State  your economic status/annum 
a. Below Rs.24,000/-       
b. Above Rs.24,000/-       
6. Marital status 
a. Married        
b. Single        
c. Divorce        
d. Widow        
7. Religion 
a .Hindu        
b .Muslim         
c. Christian        
d. Any Other        
B.   CLINICAL DATA 
8. Duration Of Illness 
          a .Below 6months         
          b .7 Months -1year        
          c. 2-6 Years          
          d. Above 6years        
9. How long on chemotherapy        
           a .1 cycle         
           b .2-3 cycle         
           c.4 -6 cycle         
           d. above 6 cycle        
10.Frequency of chemotherapy 
            a.15 days cycle        
            b.21 days cycle        
            c.30 days cycle               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART- II 
RATING SCALE TO ASSESS CHEMOTHERAPY ADVERSE EFFECTS 
The investigator read out the following statement the response will be marked 
as tick (9) as your answer. The questions will be repeated is needed 
S.NO CRITERIA SCORING 
       I PAIN  
1 No pain 1 
2 Mild 2 
3 Moderate 3 
4 Severe 4 
II SLEEP  
1 Sound sleep 1 
2 Trouble in falling a sleep 2 
3 Mid sleep awakening 3 
4 No sleep 4 
III ANOREXIA  
1 Good appetite 1 
2 Irritability of seeing food 2 
3 Feeling fullness of stomach 3 
4 No appetite 4 
IV VOMITING  
1 No vomiting 1 
2 Feeling nausea 2 
3 Difficult or painful swallowing 3 
4 Vomiting after taking food 4 
V MOUTH ULCER  
1 No ulcer 1 
2 Dryness of mouth 2 
3 Redness of mouth 3 
4 Mouth ulcer 4 
 
VI FATIGUE 1 
1 Good in regular activities 2 
2 Trouble in concentrating daily activities 3 
3 Restrict in daily activities 4 
4 Complete absent of daily activities  
VII DEPRESSION 1 
1 Happy mood 2 
2 Feeling lonely 3 
3 Not able to hope of with condition 4 
4 Depressed 3 
VIII BODY IMAGE  
1 No physical changes 1 
2 Weight loss 2 
3 Hair loss 3 
4 Disturbance self image 4 
IX SKIN CHANGES  
1 No skin changes 1 
2 Skin irritation 2 
3 Dryness of skin 3 
4 Itching of the skin color changes 4 
X BOWEL CHANGES  
1 No changes 1 
2 Diarrhea 2 
3 Constipation 3 
4 Bowel irritation 4 
Key 
1 – Normal 
2 – Mild 
3 – Moderate 
4 – Severe 
AROMA THERAPY 
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CHAPTER- I 
INTRODUCTION 
 
 ‘‘Coping with cancer can be a less frightening experience 
        When a holistic approach is integrated into the primary medical treatment’’ 
 
In most people’s mind there is no scarier diagnosis than that of cancer. Cancer 
is not a new disease.  Cancer is often thought of as an untreatable, unbearably painful 
disease with no cure. However popular this view of cancer may be, it is exaggerated 
and over-generalized. Cancer is undoubtedly a serious and potentially life-threatening 
illness. For example, it is the leading cause of death in Americans under the age of 85, 
and the second leading cause of death in older Americans.  
 
There will be 1.5 million new cases of cancer occurring in the United States 
coming year, and over 570,000 deaths because of it not including basal and squamous 
skin cancers which are not reported but could add another two million cases per year 
(ACS, 2010). 
 
The global burden of cancer continues to increase largely because of the aging 
and growth of the world population alongside an increasing adoption of cancer-
causing behaviors, particularly smoking, in economically developing countries. Based 
on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million 
cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 
64% of the deaths occurred in the economically developing world. Breast cancer is 
the most frequently diagnosed cancer and the leading cause of cancer death among 
females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. 
 
Lung cancer is the leading cancer site in males, comprising 17% of the total 
new cancer cases and 23% of the total cancer deaths. Geneva, 3 April 2003 - Cancer 
rates could further increase by 50% to 15 million new cases in the year 2020, 
according to the World Cancer Report, the predicted sharp increase in new cases – 
from 10 million new cases globally in 2000, to 15 million in 2020 - will mainly be 
due to steadily ageing populations in both developed and developing countries.                                    
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 It is estimated that about 9 million new cancer cases are diagnosed every year 
and over 4.5 million people die from cancer each year in the world. 
 
The estimated number of new cancers in India per year is about 7 lakhs and 
over 3.5 lakhs people die of cancer each year. Out of these 7 lakhs new cancers about 
2.3 lakhs (33%) cancers are tobacco related. There would be about 1.5 lakhs cancer 
cases at any given time in Karnataka and about 35,000 new cancer cases are added to 
this pool each year. Over 16,000 new cases are registered every year with more than 
20 % from neighbouring states of Andhra Pradesh , Tamil Nadu and Kerala. 
 
In Chennai, the total cancer burden  is predicted to increase by 32% by 2012- 
16 compared with 2002-06, with 19% due to changes in cancer risk and a further 13% 
due to the impact of demographic changes. The annual cancer burden predicted for 
2012-2016 is 6100 for Chennai, translating to 55000 new cases per year statewide in 
Tamilnadu. 
 
In Madurai out of one crore population covering six districts in south Tamil 
Nadu, 12,000 cancer cases were reported every year, said P.K. Muthukumarasami 
Head of Department  Medical Oncology, Government Rajaji Hospital. 
 
In a study reported in the Lancet, they used a double-blind, placebo-controlled 
randomized trial, which means that the control group did not take the medicine, and 
the people doing the study did not know who was receiving the real drug or the 
placebo. In addition, people were placed in groups randomly, or by chance. Over 200 
survivors of breast cancer who had significant hot flashes were entered into the study. 
Fifty-six were in the control group, and the other women were placed in one of three 
groups depending upon the dose of venlafaxine (37.5 mg, 75 mg, or 150 mg). The 
women took the medicine for four weeks. At the end of four weeks, the women in the 
placebo group had 27% lower scores, the group taking a dose of 337.5 mg a day had 
37% lower scores, and the women taking either 75 or 150 mg of the drug had 61% 
lower hot flash scores. Side effects of venlafaxine included dry mouth, decreased 
appetite, nausea, and constipation.  
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OVERVIEW ABOUT CANCER AND MANAGEMENT 
Introduction 
The Greek physician Hippocrates is believed  to  be  the  first  person  to use 
the word “carcinos”, which  describes  the  crab-like   way  that  both  the  ulcer-
forming  and  non-ulcer forming tumors spread .Over time ,the word shortened to“ 
cancer”. 
 
When the first autopsy was performed by Italian anatomist Giovanni 
Morgagni in 1761, the foundation was laid for the scientific study of cancer, also 
known as oncology. 
 
Cancer 
Cancer is a disease characterized by uncontrolled, uncoordinated and 
undesirable cell division.  
 
Cancer is not just one disease but many diseases. There are more than 100 
different types of cancer. Most cancers are named for the organ or type of cell in 
which they start - for example, cancer that begins in the colon is called colon cancer; 
cancer that begins in basal cells of the skin is called basal cell carcinoma. 
 
Types         
           Not all tumors are cancerous; tumors can be benign or malignant. 
• Benign tumors aren't cancerous. They can often be removed, and, in most 
cases, they do not come back. Cells in benign tumors do not spread to other 
parts of the body. 
• Malignant tumors are cancerous. Cells in these tumors can invade nearby 
tissues and spread to other parts of the body. The spread of cancer from one 
part of the body to another is called metastasis. 
    
Causes 
            Cancer is caused by damage to DNA. The body is usually able to repair 
damaged DNA, but is unable to do so in cancer cells.  
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            Some people inherit damaged DNA, but in most cases people damage it 
themselves through lifestyle choices such as smoking, exposure to ultraviolet 
radiation (UV) from the sun or exposure to cancer-causing substances known as 
carcinogens in the environment, like asbestos. 
 
      Symptoms                          
• C-Changes in bowel or bladder habits  
• A-A sore that does not heal  
• U-Unusual bleeding or discharge 
• T-A thickening or lump in any part of the body 
• I-Indigestion or difficulty swallowing  
• O-obvious changes in a wart or mole  
• N-A nagging cough or hoarseness  
 
Prevention  
         There are a number of ways to reduce the chance of getting cancer, including:  
• Not using tobacco products  
• Choosing foods low in fat  
• Eating a diet rich in vegetables, fruits, and whole grains  
• Exercising regularly  
• Maintaining a healthy weight  
• Avoiding over-exposure to the sun 
Cancer management 
           Alert people to the 3 –earlier of cancer control: 
                        ‘’   Early detection’’ 
                        ‘’   Early diagnosis’’ 
                        ‘’  Early treatment’’ 
• Conventional cancer treatment can include surgery, radiation, chemotherapy, 
hormone therapy, and biological therapy.                         
• Complementary medicine   
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Chemotherapy 
            It is used to kill cancer cells anywhere in the body, including cells that have 
broken off from a main tumor and traveled through the blood or lymph systems to 
other parts of the body. 
 
Side effects                           
• Nausea and vomiting 
• Fatigue  
• Hair loss  
• Susceptibility to infections  
• Decrease in blood cell count 
• Mouth sores and ulcers 
 
Complementary medicine 
Complementary therapies are supportive approaches that can improve well-
being and quality of life of people with cancer. 
 
           Complementary therapies are taken in conjunction with conventional 
treatments. This therapy includes herbs, acupuncture, acupressure, natural remedies, 
yoga ,massage, spiritual practices  ,green tea ,specific diet ,ayurvedic medicine 
,relaxation and  meditation ,prayers ,vitamins ,biofield therapies such as Pranics 
Healing, Homeopathy ,Naturopathy ,Reiki ,and  others. Use of these therapies is 
common in the general population. 
 
Aromatherapy  
Aromatherapy is a natural, healing modality employing essential oils extracted 
from aromatic plant sources to treat and balance the body, mind and spirit. Smell 
stimulates parts of our  brain that control our emotions ,moods ,memory and learning. 
Smell reaches these parts of these parts of the brain through cilia, which are the fine 
hair lining the nose. 
 
It also can improve our complexion ,stimulate creativity ,reduce stress and 
help us to sleep calmly.     
 
Sensory complementary therapies are  that work in conjunction with the five 
senses: smell, site, taste, sound and touch, as well as the body's overall energy. 
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SIGNIFICANCE AND NEED FOR THE STUDY 
In the year 2000, malignant tumors were responsible for 12 per cent of the 
nearly 56 million deaths worldwide from all causes. In many countries, more than a 
quarter of deaths are attributable to cancer. In 2000, 5.3 million men and 4.7 million 
women developed a malignant tumor and altogether 6.2 million died from the disease. 
Importantly, almost half of them can be expected to be cured (not palliated alone) 
with modern medicine.  
 
Chemotherapy is generally used to treat cancer that has spread or metastasized 
because the medicines travel throughout the entire body. It is a necessary treatment 
for some forms of leukemia and lymphoma. Chemotherapy treatment occurs in cycles 
so the body has time to heal between doses. However, there are still common side 
effects such as hair loss, nausea, fatigue, and vomiting. Combination therapies often 
include multiple types of chemotherapy or chemotherapy combined with other 
treatment options.Their meticulous study was based on an analysis of the results of all 
the randomized, controlled clinical trials (RCTs) performed in Australia and the US 
that reported a statistically significant increase in 5-year survival due to the use of 
chemotherapy in adult malignancies. Survival data were drawn from the Australian 
cancer registries and the US National Cancer Institute's Surveillance Epidemiology 
and End Results (SEER) registry spanning the period January 1990 until January 
2004. 
 
The use of complementary therapies is increasing in India where many people 
with cancer are using these therapies on a regular basis. Health professionals are 
increasingly seeing some of these therapies as useful, particularly their potential for 
dealing with side effects of treatment and the emotional well being of patients (Boon, 
2000) with cancer. 
 
In one study, disclosure of the use of these therapies increased from a lesser to 
greater percent (Downer, 1994) when directed questions were added to standard 
history taking. Nurses should also take a leading role in promoting evidence-based 
practice, and conducting nursing research on the beneficial effects of complementary 
therapies. 
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‘‘Coping with cancer can be a less frightening experience when a holistic 
approach is integrated into the primary medical treatment’’. With the aim of above 
mentioned statement, the investigator   felt the need of research in evaluating the effect 
of aromatherapy as complementary in conjunction with chemotherapy. In order to 
alleviate the side effects of chemotherapy and also the investigator had personal 
experience with find many cancer patients on chemotherapy who are suffering with 
side effects like nausea, vomiting, hair loss, loss of appetite, diarrhea and constipation 
etc. she had insight to introduce some innovational technique in reducing above 
mentioned symptoms and thereby improving the quality of life with cancer.  Hence the 
investigator felt the need to study the effectiveness of aromatherapy on reducing 
chemotherapy effects. 
 
STATEMENT OF THE PROBLEM 
             A study to evaluate the effectiveness of aromatherapy on selected adverse 
effects among   patients undergoing chemotherapy at cancer centre in Madurai. 
 
OBJECTIVES 
1. To assess the adverse effects of Chemotherapy before aromatherapy among 
control group and experimental group. 
2. To assess the adverse effects of Chemotherapy after aromatherapy  among 
control group and experimental group. 
3. To find out the effectiveness of aromatherapy on adverse effects  among 
patients on chemotherapy. 
4. To find out the association between aromatherapy and selected   demographic     
variables. 
 
NULL HYPOTHESIS 
H01: There will be no significant difference between pretest and post test score 
regarding effectiveness of aromatherapy on selected adverse effects among   
patients undergoing chemotherapy. 
H02: There will be no significant association between pretest and post test score 
regarding effectiveness of aromatherapy on selected adverse effects among   
patients undergoing chemotherapy with selected demographic variables. 
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OPERATIONAL DEFINITION  
Effectiveness 
In  this  study,  it  refers  that   the  outcome  of  aromatherapy  as  shown      
from the  Significant mean difference between pretest and post test scores among 
patients on chemotherapy. 
 
Aromatherapy 
In this study it refers that it is therapeutic procedure in which                       
inhalation of 5ml of lavender oil mixing with 500ml of boiled water for duration of 
15-20 minutes for 5 days.                 
 
         Selected adverse effects 
          In this study it involves the physical, psychological and social                       
Manifestation due to exposure of chemotherapy as measured by the rating scale to 
assess the chemotherapy side effects. 
 
           Patients on Chemotherapy therapy 
            In this study, it refers that among patients undergoing chemotherapy who 
fulfills inclusion criteria. 
          
ASSUMPTION 
• There will be a significant effectiveness of aromatherapy on selected adverse   
effects   among   patients on   chemotherapy   therapy. 
• Chemotherapy adverse effects are different from each individual. 
 
DELIMITATION 
• The  study  was  not  done  to  all  the  stages  of  cancer. 
• The study was conducted on less number of subjects in                        
one setting which the generalization.  
 
PROJECTED OUTCOME 
Use of aromatherapy among patients with chemotherapy adverse  effects will 
help to bring about a significant physical, psychological effect that enhances support, 
comfort and relaxation and overall outlook of the patients.                                                                 
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CHAPTER-II 
REVIEW OF LITERATURE 
 
 The chapter deal with the studies relevant to the present study .It is presented 
under the following headings. 
 
• Review related to cancer 
• Review related to chemotherapy effects 
• Review related to aromatherapy 
• Review related to aromatherapy on chemotherapy effects 
REVIEW RELATED TO CANCER 
 Kutner et.al (1927) conducted study at the School of Medicine, College of 
Nursing, and School of Public Health, University of Colorado Denver, Denver and 
Aurora, Colorado, and Florida Atlantic University, Boca Raton, Floridato evaluate the 
efficacy of massage for decreasing pain and symptom distress and improving quality of 
life among persons with advanced cancer. 380 adults with advanced cancer who were 
experiencing moderate-to-severe pain; 90% were enrolled in hospice and given 30-
minute massage or simple-touch sessions over 2 weeks: 298 persons were included in 
the immediate outcome analysis and 348 in the sustained outcome analysis. A total of 
82 persons did not receive any allocated study treatments (37 massage patients, 45 
control participants). Both groups demonstrated immediate improvement in pain 
(massage, −1.87 points [95% CI, −2.07 to −1.67 points]; control, −0.97 point [CI, 
−1.18 to −0.76 points]) and mood (massage, 1.58 points [CI, 1.40 to 1.76 points]; 
control, 0.97 point [CI, 0.78 to 1.16 points]). Massage was superior for both immediate 
pain and mood (mean difference, 0.90 and 0.61 points, respectively; P < 0.001). No 
between-group mean differences occurred over time in sustained pain (BPI mean pain, 
0.07 point [CI, −0.23 to 0.37 points]; BPI worst pain, −0.14 point [CI, −0.59 to 0.31 
points]), quality of life (McGill Quality of Life Questionnaire overall, 0.08 point 
[CI,−0.37 to 0.53 points]), symptom distress (Memorial Symptom Assessment Scale 
global distress index, −0.002 point [CI, −0.12 to 0.12 points]), or analgesic medication 
use (parenteral morphine equivalents, −0.10 mg/d [CI, −0.25 to 0.05 mg/d]). Massage 
may have immediately beneficial effects on pain and mood among patients with 
advanced cancer. Given the lack of sustained effects and the observed improvements in 
both study groups, the potential benefits of attention and simple touch should also be 
considered in this patient population.  
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             Michele.l (2007)conducted study at Wayne State University and the Barbara 
Ann Karmanos Cancer Institute, a two year, $100,000 grant to examine the role of 
estrogen-related tumor characteristics in predicting sex-specific survival after a lung 
cancer diagnosis.Lung cancer is a rapidly fatal disease for the majority of individuals 
diagnosed, with an overall five year survival rate of just 15 percent. Women have a 
slightly better survival rate than men do, suggesting hormones could play a role in 
cancer prognosis.“In the late 1980s and early 1990s, researchers found estrogen 
receptors (the receptors that control estrogen metabolism) in lung cancers, which was 
startling, as the lung wasn’t expected to be a hormone-dependent tissue,” explained 
Coté, who has been with the Karmanos Cancer Institute since 1999. 
 
 REVIEW RELATED TO CHEMOTHERAPY EFFECTS 
 Lisa colodny et.al conducted study at Hauppague ,New York to assess the 
effectiveness of the dietary supplement propax’with NT factor in reducing 
chemotherapy –induced fatigue ,nausea and vomiting ,and other selected clinical side 
effects associated with chemotherapy.using a crossover placebo –controlled 
,randomized ,double-blinded design ,36 patients with cancer were enrolled in the 12 –
week pilot study .simultaneously ,an open label trailof propax’in 22 other patients 
with cancer was similarly implemented.recommended daily dose of the study product 
was 12 tablets and 3 softgel capsules daily.the result of this pilot study ,both open –
label and double –blinded placebo-crossover in design,indicatesthat patient perception 
of benefit with propax’supplementation to chemotherapy is significant in reducing 
fatigue and other chemotherapy –induced toxicities.  
 
 Coolbrandt A et.al(2011)  conducted study at Euro the purpose of this study 
was to founded the correlation between immediately reported symptoms and thoe 
recalled during the next hospital visit.Data from the first 7 questionnaires were 
aggregated into a single score per symptom per patient, and the maximum score was 
considered to be the most clinically relevant (consistent with the National Cancer 
Institute's guidelines). The researchers emphasized the rationale for this approach, 
noting that for symptoms like chemotherapy-induced nausea and vomiting, it is 
important to obtain insight as to how bad symptoms were at the time they occurred 
rather than an average of good and bad days. They further speculated that patients 
would not recall their worst symptoms when asked about them at the next hospital 
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visit but would instead tone down or average their good and bad days. Therefore, the 
analyses also examined correlations and differences between immediate and delayed 
self-reported symptom severity on the basis of median score of the immediate self-
report. 
 
 Spichiger E, etal(2011) conducted study at Institute of nursing science, 
Switzerland. This study was part of a larger project that explored patients ‘s symptom 
experiences during chemotherapy . In this qualitative study, 19 patients with 
lymphomas, breast, lung or colorectal cancer participated concurrently with treatment 
at a Swiss tertiary care hospital's oncology outpatient clinic. Data on patients' fatigue 
experiences were collected via individual interviews following their third cycle of 
chemotherapy  At the start of their chemotherapy, health professionals informed 
patients that common side effects included fatigue. While all participants experienced 
different dimensions of fatigue, then, all were willing to endure it for the sake of an 
expected improvement in their conditions. Individuals' fatigue experiences depended 
largely on their particular life and illness circumstances. Most engaged in fatigue-
related self-care activities and managed the symptom on their own. Communication 
with or input from health professionals was virtually absent during chemotherapy. 
 
 Serrano Solares.S (2009) conducted study American society of clinical 
oncology.  This study’s objective is to estimate the prevalence of chemotherapy 
adverse events in oncologic patients attended in Emergency room.  From October 
2007 to October 2008 560 patients were recollected. It was revised tumors location 
and stage, chemotherapy schedule and date of the last treatment, diagnosis and 
therapheutic in Emergency.  87 of the 560 patients (15%) were attended in Emergency 
room because of chemotherapy toxicity. The most common cause of consultation was 
fever (27 patients, 31%) followed by diarrhea (18 patients, 20.7%) and nausea-
vomiting (12 patients, 13.8%). Most of the patients were being treated with classic 
chemotherapy schedules (70.1%). Comparing as a whole all the chemotherapy 
schedules there were not statistically significant differences due to toxicity between 
them. Nevertheless analyzing by subgroups we found there was no difference between 
toxicity in patients treated with classic chemotherapy and chemotherapy plus target 
agents (33.8% vs 5.5%, p=0.30), but there was differences between chemotherapy and 
target agents in monotherapy (33.8% vs 13.2%, p<0.05). In 39 of the 87 patients 
(39%) admission was required with a good evolution in most of them. 
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REVIEW RELATED TO AROMATHERAPY                                      
              Taehan Kanho Hakhoe (2006)  conducted study at Lee GJ. Department of 
Nursing, Keukdong College, Chungcheongbuk-Do, Korea.The purpose of this study 
was to explore the effects of the lavender fragrance on sleep and depression in women 
college students. Forty-two women college students who complained of insomnia were 
studied during a four-week protocol (control treatment week, 60% lavender fragrance 
treatment week, washout week, 100% lavender fragrance treatment week). All subjects 
were in the department of nursing in “K” college and the study was a single blind 
repeated measurements experiment. For the duration of the study, weekly evaluations 
of sleep, patterns of sleep disturbance, severity of insomnia scale, self satisfaction with 
sleep, and severity of depression were performed. Among sleep variables, length of 
time taken to fall asleep, severity of insomnia, and self satisfaction with sleep were 
improved for the 60%(p=.000, p=.000, p=.000) and 100%(p=.000, p=.000, p=.000) 
week while the severity of depression was improved only for the 100%(p=.002) week. 
According to the study results, it can be concluded that the lavender fragrance had a 
beneficial effect on insomnia and depression in women college students. Repeated 
studies are needed to confirm effective proportions of lavender oil and carrier oil for 
insomnia and depression. 
 
 Hitomi Takeda, et.al (2008)conducted study at, Hyogo College of Medicine, 
Hyogo, Japan.The purpose of this study was to evaluate the effects of aromatherapy 
body treatment on healthy subjects Seven (7) female and 6 male volunteers 
participated as subjects. Each subject underwent 3 trials, in which the Advanced Trail 
Making Test (ATMT) was given as a stress-inducing task before and after 1 of 3 
treatments. After the treatments, the state anxiety inventory (SAI) score and the 
feelings of fatigue were decreased, the positive and comfortable feelings were 
increased, and mood improved significantly in C and E. Furthermore, significant 
declines in the feelings of mental and total fatigue were maintained even after the 
second ATMT in E. On the other hand, the cortisol concentration in the saliva did not 
show significant changes in any of the trials. Secretary immunoglobulin A levels in 
the saliva increased significantly after all treatments. 
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 Jung .t et.al (2006) conducted study at New York medical center   to 
evaluation of aromatherapy in treating postoperative pain. This study compared the 
analgesic efficacy of postoperative lavender oil aromatherapy in 50 patients 
undergoing breast biopsy surgery. Twenty-five patients received supplemental oxygen 
through a face mask with two drops of 2% lavender oil postoperatively .The 
remainder of the patients received supplemental oxygen through a face mask with no 
lavender oil. Outcome variables included pain scores (a numeric rating scale from 0 to 
10)at5,30and 60 minutes postoperatively ,narcotic requirements in the post anesthesia 
care unit ,patient satisfaction with pain control ,as well as time to discharge from the 
PACU. There were no significant difference in narcotic requirements and recovery 
room discharge times between the two groups .postoperative lavender oil 
aromatherapy did not significantly affect pain scores .however ,patients in the 
lavender group reported a higher satisfaction rate with pain control than patients in the 
control group(p=0.0001).                 
 
Tim Jacobs, conducted study at Cardiff University, compared the effects of 
two essential oils on the alpha waves of the brain. One oil, Rosemary, was known to 
have a stimulant effect and the other, Ylang-Ylang, was known to have a soothing 
effect. The study showed that the stimulant depressed alpha wave activity whereas the 
soothing aroma increased alpha wave activity. This data is consistent with the 
expected results.  
  
 Another study by Jahangeer, Melluier, and Caston published in Physiology 
and Behavior looked at the influence of olfactory stimulation on nociceptive behavior 
in mice. They hypothesized that because the cerebral localization of pain and the 
olfactory pathways are anatomically and physiologically linked, olfactory stimulation 
can modify the response of the mice to painful stimuli in the presence of positive 
(attractive), negative (aversive), or neutral odors. 
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REVIEW TO RELATED AROMATHERAPY ON REDUCING 
CHEMOTHERAPY EFFECTS 
   
              Torry et.al.(2003) conducted an exploratory study in college of nursing,Lowa 
City, to examine the effects of aromatherapy effects on nausea, vomiting ,and 
pain.aromatherapy for 20 minutes duration was given to nine in  patients for three 
days .the patients self report measured by rating scale before and after the intervention 
the results shown that aromatherapy significantly reduced the symptoms and increase 
relaxation to about 58%.In addition to this subjective data, all vital parameters tended 
to decrease providing further evidence of relaxation .In conclusion ,the aromatherapy 
is a beneficial nursing intervention that promotes relaxation.                   
 
              Hiroyuki Kohara et.al (2004)   conducted study at National Sanyo Hospital, 
Yamaguchi, Japan.  Fatigue is one of the most distressful symptoms experienced by 
patients with advanced cancer. Aromatherapy, foot soak, and reflexology are popular 
health care modality treatments in Japan, however, the effectiveness of each 
treatment for cancer-related fatigue has not been fully established. To investigate the 
effectiveness of combined modality treatment consisting of aromatherapy, foot soak, 
and reflexology against fatigue, an open study was performed in 20 terminally ill 
patients with cancer. After a patch test was performed, patients received 
aromatherapy that was accompanied with foot soak in warm water containing 
lavender essential oil for 3 minutes, followed by reflexology treatment with jojoba 
oil containing lavender for 10 min. Fatigue was evaluated using the Cancer Fatigue 
Scale (CFS) before, 1 hour after, and 4 hours after treatment. Total CFS scores 
improved significantly after this treatment (from 25.6 ± 11.0 to 18.1 ± 10.0, p < 
0.001). Among three CFS subscales, physical and cognitive subscale scores were 
reduced significantly (11.3 ± 6.1 to 6.7 ± 6.1, p < 0.001; 4.5 ± 3.2 to 2.4 ± 2.4, p < 
0.001). No adverse effects were experienced. Because all patients desired to continue 
this treatment, they received treatment eight times on average. 
 
            Grealish et.al. (2006) concluded in this study that the use of aromatherapy is a 
non pharmacological measures by nurses to alleviate pain and nausea in cancer 
patients who are hospitalized. 
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            Karen moody (2008)conducted study at Montefiore Medical Center the 
proposed study aims to assess the effectiveness of aromatherapy versus placebo on 
nausea, vomiting, anxiety and quality of life among pediatric oncology patients 
receiving emetogenic chemotherapy. Patients aged 7-21 with a diagnosis of cancer 
and will be receiving emetogenic chemotherapy Nausea and vomiting remain two of 
the most distressing symptoms to children being treated for cancer. Nausea and 
vomiting are directly associated with the administration of chemotherapy, due to 
effects of the chemotherapy on the gastrointestinal mucosa, and certain 
chemotherapeutic agents, such as cisplatin, are known to be particularly emetogenic. 
In addition, anticipatory anxiety has been identified as an important patient factor in 
the development of post-chemotherapy nausea and vomiting. Many drugs have been 
developed in an effort to diminish nausea and vomiting in children receiving 
emetogenic chemotherapy and these agents, particularly the 5-hydroxytryptamine 
receptors, have vastly reduced the amount of nausea and vomiting experienced in this 
population. However, approximately 50% of children and adolescents still suffer 
from nausea and/or vomiting even after maximal pharmacological intervention. This 
suggests that other interventions are needed to further reduce the experienced nausea 
and vomiting seen in children undergoing chemotherapy. As such, many patients and 
providers have turned to complementary and alternative medicine (CAM) for the 
relief of nausea and vomiting. Aromatherapy is one such modality that has 
demonstrated some degree of effectiveness in adults suffering from nausea and 
vomiting due to chemotherapy, motion sickness, or postoperatively. 
 
           Young – IM et.al.(2004) conducted a study to determine the effects of 
aromatherapy on nausea ,vomiting ,and pain in high dose of chemotherapy. They 
concluded by saying that all the above variable shown a significant decrease after the 
intervention. 
 
Yang JH (2005) quoted in this study that aromatherapy was effective on 
vomiting ,nausea, and fatigue in receiving chemotherapy .therefore aromatherapy can 
be implemented as a nursing modality  for patients receiving chemotherapy.  
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CONCEPTUAL FRAMEWORK 
 
The conceptual framework selected for the study is based on the nursing 
process is a modified scientific method .Nursing practice was first described as a four 
stage nursing process by Ida Jean Orlando in 1958. Now it is six stage process, the 
nursing process uses clinical judgment to strike a balance of Epistomology between 
personal interpretation and research evidence in which critical thinking may play a 
part to categorize the clients issue and course of action. The nursing process is goal-
oriented method of caring that provides a framework to nursing care. It involves five 
major steps: 
 
• A - Assessment  
• D - Diagnosis 
• G-Goal  
• P - Planning  
• I - Implementation 
• E – Evaluation 
 
Assessment 
            In assessment phase the examiner evaluates the disease or condition based on 
the patient’s subjective report of the symptoms and course of the illness, together with 
the objective data obtained through laboratory tests, physical examination and 
medical history. 
 
              In this study it includes subjective data and objective data collected as  
demographic data, clinical data and rating scale to assess chemotherapy adverse 
effects used as pretest. 
 
Diagnosis  
            Nursing diagnosis represent the nurse's clinical judgment about actual or 
potential health problems, life process occurring with the individual, family, group or 
community .In this study patients problems were pain, nausea, vomiting ,mouth ulcer, 
fatigue, and bowel changes. 
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Goal 
          In this phase it represents outcome identification.  
Planning 
           The nurse addresses each of the problems identified in the diagnosing phase. 
When there are multiple nursing diagnoses to be addressed, the nurse prioritizes 
which diagnoses will receive the most attention first according to their severity and 
potential for causing more serious harm.  
 
           In this study planning refers that to give aromatherapy for continuous five days 
about 15-20 minutes to the patients with chemotherapy adverse effects as a nursing 
intervention.  
 
Implementation 
           The nurse implements the nursing care plan, performing the determined 
interventions that were selected to help meet the goals/outcomes that were 
established. 
 
           In this study intervention has been taken place and implement the nursing care 
plan that is aromatherapy given for continuous five days about 15-20 minutes. 
 
Evaluation 
           The nurse evaluates the progress toward the goals/outcomes identified in the 
previous phases. If progress towards the goal is slow, or if regression has occurred, 
the nurse must change the plan of care accordingly. 
 
           In this study evaluated chemotherapy adverse effects through rating scale on 
fifth day used  as a post test. 
                              
           
 
 
 
 
 
 
18 
FIGURE: 1 CONCEPTUAL FRAME WORK
NURSING PROCESS MODEL- ORLANDO (1958)
PRETEST 
SUBJECTIVE DATA 
Demographic Variables 
Age, Sex, Education, 
Occupation, Religion, 
Economic Status and 
Marital Status  
Clinical Data 
Duration of illness, System 
Affected, Frequency of 
Chemotherapy, and Number 
of cycle.  Pain, Vomiting 
loss of Appetite, 
constipation and diarrhea. 
OBJECTIVE DATA 
Rating scale 
To assess chemotherapy 
adverse effects pain, 
vomiting  loss of appetite, 
constipation and diarrhea. 
 
 
Risk for complications 
related to 
chemotherapy as 
manifested by rating 
scale assessment 
 
To give 
Aromatherapy 
for continuous 5 
days about 15-
20 minutes. 
 
Given 
Aromatherap
y for 
continuous 5 
days about 
15-20 
minutes 
 
POST TEST 
Chemotherapy 
adverse effects 
reduced. 
 
Chemotherapy 
adverse effects 
not reduced 
          Feedback 
ASSESSMENT NURSING 
DIAGNOSIS 
 
PLANNING 
IMPLEMEN
TATION
EVALU
ATION
GOAL 
Patients will be 
relieved from 
complications. 
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CHAPTER III 
METHODOLOGY 
                                      
Research methodology of this study includes the research approach, research 
design, setting of the study, population, sampling technique, sample size, criteria for 
sample selection and description of the tool, validity, reliability, pilot study and 
method of data collection, data analysis and protection of human subjects. 
 
RESEARCH APPROACH 
              An Experimental approach was used to evaluate effectiveness of                        
aromatherapy on selected adverse effects among   patients on chemotherapy. 
 
RESEARCH DESIGN 
A quasi experimental design was adopted with pretest- posttest control group 
design to evaluate effectiveness of aromatherapy on selected adverse effects among 
patients on chemotherapy. 
 
VARIABLES 
Independent variables 
In  this study  the  Aromatherapy   was  independent  variable.  
Dependent variables 
The chemotherapy adverse effect was the dependent variable in the study. 
Extraneous variables 
The extraneous variables in this study were age ,sex ,religion, educational 
status, occupation, income ,cancer affected system, duration of chemotherapy, and 
frequency of chemotherapy.                         
      
SETTING OF THE STUDY   
The study was conducted in Guru Cancer centre at Madurai. It is situated at 
Pikkara,1km away from our college. It has strength of 50 bedded and provides regular 
treatment on inpatient and outpatient’s basis .This cancer centre serves to all 
economic status in the society and provides free treatment. 
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POPULATION  
       The target population includes among patients on chemotherapy with                        
selected adverse effects. 
 
           The accessible population includes all the patients with cancer enrolled at 
selected hospital, in Madurai. 
 
SAMPLE  
            The samples for the study were the patients with cancer and under treatment 
of chemotherapy on selected adverse effects who fulfills inclusion criteria. 
 
SAMPLE SIZE 
The samples for the study were 60 among patients on chemotherapy  with  
selected adverse effects.30 patients were selected as experimental group and 30 
patients were selected as control group who fulfilled the inclusion criteria.          
 
SAMPLE TECHNIQUES 
The sample technique was selected by using non randomized sampling 
technique of purposive sampling method. The investigator has selected the samples 
from male and female patients came for chemotherapy and with adverse effects. 
Purposive Sampling is sub types of non- probability sampling techniques. 
 
CRITERIA FOR SAMPLE SELECTION 
Inclusion Criteria 
• Patient’s undergone chemotherapy. 
• Both gender on chemotherapy. 
Exclusion Criteria: 
• Patients practicing meditation or yoga 
• Epilepsy/seizure disorder 
• Hypoglycemia 
• Kidney problems 
• pregnancy 
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DESCRIPTION OF THE TOOL   
The instrument was developed by the investigator with the help of various       
resources which includes review of literature, expert opinion. The instrument 
comprised of 3 parts 
 
Part I  –    a) Demographic variables 
                                  b) Clinical variables 
Part II – Rating scale to assess the chemotherapy side effects 
 
Part I(a) 
It consists of demographic variables of patients such as age, sex, religion, 
education, occupation, economic status, and marital status. 
 
Part I (b) 
It consists of clinical data such as duration of illness, system is affected by 
cancer, frequency of chemotherapy, how long on  chemotherapy, and cycle  duration. 
 
Part II 
Rating scale to assess the chemotherapy side effects which consists of 10 
items. It was used to assess the chemotherapy adverse effects. Patients  were asked to 
choose the best response. Responses were scored as 
 
1-Normal 
2-Mild 
3-Moderate 
4- Severe 
Scoring Procedure 
              The assessment aspects placed on a rating scale .the scale consists of  10 
items in 4 aspects of question to be rated as normal, mild ,moderate , severe.1 
indicates normal,2 indicates mild , 3 indicates moderate, and 4 indicates severe  a total 
score  of 40.  
 
               Total score is divided as: 
1-10-normal 
11-20- mild 
21-30-moderate 
31-40-severe 
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VALIDITY OF THE TOOL 
 Seven experts validated the tool and used in this study .The tool was evaluated 
for appropriateness, adequacy ,relevance ,completeness and comments and 
suggestions were invited and appropriate modification were made accordingly .The 
tool was refined and finalized after establishing the validity . 
  
RELIABILITY OF THE TOOL 
The reliability was tested by using the test split half method and found the tool 
is reliable for my study. The tool was administered to 6 patients undergoing 
chemotherapy in Devakhi hospital.                                                 
 
 The coefficient was found as 0.97 which shows the excellent reliability of the 
tool. 
 
DATA COLLECTION PROCEDURE 
 The written permission obtained from authorities at Guru cancer centre in 
Madurai. The data collected among patients on chemotherapy adverse effects. The 
period of data collection was 6 weeks .The total number of patients was 60, in which 
30 belongs to the experimental group, and 30 to the control group .Informed consent 
was obtained in the written form .Initially good rapport  was maintained with the 
patients and the purpose of the study was explained to them. Patients were made 
comfortable and privacy was provided. Pretest was conducted through the 
demographic variables, clinical data and rating scale to assess the chemotherapy 
adverse effects.  The patients in the experimental group were given  aromatherapy 
lavender oil 5ml mixed with boiled water and asked patients to inhale for 15-
20minutes.the patients in the control group were given the usual treatment .The 
selected adverse effects was assessed on the first day and  fifth  day in both the 
groups. All the subjects   were co operated well. 
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DATA COLLECTION SCHEDULE     
 
Weeks 
Experimental group Control group 
No of 
samples 
Pretest and 
intervention 
Post 
test 
No of 
samples Pre test 
Post 
test 
I&II 15 Pretest on 
admission 
followed by 
aromatherapy
Post test 
on 5th 
day 
15 Pre test on 
admission 
Post on 
5th day 
III&IV 15 Pretest on 
admission 
followed by 
aromatherapy
Post test 
on 5th 
day 
15 Pre test on 
admission 
Post on 
5th day 
 
PLAN FOR DATA ANALYSIS 
 The data analysis is the systematic organization and synthesis of research of 
research data and testing hypothesis .It involves of information into interpretable and 
managing form. The data obtained was analyzed by using both descriptive and 
inferential statistics. 
 
PILOT STUDY 
 The pilot study conducted among six patients on chemotherapy with adverse 
effects who fulfilled the inclusion criteria of sample selection (3for experimental and 
3 for control) at Devakhi cancer centre in Madurai after obtaining formal permission 
from the authorities. Pre test was conducted followed by aromatherapy inhalation 
given to the experimental group. Post test done on 5th day and the adverse effects were 
assessed by the rating scale. 
 
 The time taken was completed .The tool was found to be satisfactory in terms 
of simplicity and clarity. Based on the time for collecting the data, arbitrary decision 
was taken to keep the sample size to 60.    
 
PROTECTION OF HUMAN RIGHTS 
 The proposed study was conducted after the approval of the dissertation 
committee of the college. Permission was obtained from the coordinator of the cancer 
centre, Madurai written consent of each subjects were obtained before starting the 
data collection .Assurance was given to them that the anonymity of each individual 
would be maintained.    
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CHAPTER-IV 
DATA ANALYSIS AND INTERPRETATION 
 
This chapter deals with the data analysis of data collected from the sample of 
60 patients undergoing chemotherapy. Using inferential and descriptive statistics 
based on the objectives of the study, the data were computed . 
 
The findings were organized and presented in the following sections: 
1. Distribution of undergoing chemotherapy patients based on demographic 
variables. 
2. Distribution of patients based on level of adverse effects before aromatherapy 
in experimental  and control group  
3. Distribution of  patients based on  level of adverse effects   after aromatherapy 
in experimental  and control group 
4. Distribution of effectiveness of aromatherapy on adverse effects of 
chemotherapy in experimental  and control group  
5. Difference between pretest level of adverse effects  in control and 
experimental group 
6. Difference between pretest level of adverse effects  in control  and 
experimental group 
7. Distribution association between the adverse effects with selected 
demographic variables in the experimental group among cancer patients 
undergoing chemotherapy 
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TABLE 1 DISTRIBUTION OF SELECTED ADVERSE EFFECTS BASED ON 
DEMOGRAPHIC VARIABLES 
N=60 
S. No 
  
Demographic variables 
Experimental group 
n=30 
Control group 
n=30 
no % no % 
1 Age in years 
  a) 21-30 2 6.66 0 0 
  b) 31-40 11 36.67 13 43.33 
  c)41-50 6 20 11 36.67 
  d)50 and above 11 36.67 6 20 
2 Sex 
  a)male 6 20 4 13.33 
  b)female 24 80 26 86.67 
3 Education 
  a)educated 9 30 10 33.33 
  b)uneducated 21 70 20 66.67 
4 Occupation 
  a)coolie 18 60 12 40 
  b)private employee 4 13.33 5 16.67 
  c)government employee 1 3.33 1 3.33 
  d)business 0 0 0 0 
  e)retired 0 0 0 0 
  f)others 7 23.34 12 40 
5 Income 
  a)below 24000/- 2 6.67 2 6.67 
  b)above 24000/- 28 93.33 28 93.33 
6 Marital status 
  a)married 29 96.67 29 96.67 
  b)single 0 0 0 0 
  c)divorce 0 0 0 0 
  d)widow 1 3.33 1 3.33 
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7 Religion 
  a)Hindu 27 90 25 83.33 
  b)Muslim 1 3.33 3 10 
  c)Christian 2 6.67 2 6.67 
  d)others 0 0 0 0 
8 Duration of illness 
  a)below 6 months 5 16.67 4 13.33 
  b)7-months-1year 22 73.33 22 73.34 
  c)2- 6 years 3 10 4 13.33 
  d)above 6 years 0 0 0 0 
9 
Frequency of 
chemotherapy 
  a) 15 days cycle 1 3.33 1 3.33 
  b) 21 days cycle 29 96.67 29 96.67 
  c)30 days cycle 0 0 0 0 
10 How long on cycle  
  a)1 st cycle 0 0 0 0 
  b) 2-3 cycle 12 40 10 33.33 
  c) 4-6cycle 18 60 20 66.67 
  d) above 6 cycle 0 0 0 0 
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Table 1 reveals that among 60 patients majority 11(36.67%) of them were 
between 31-40years and above 50 years in experimental group, in control group 
patients majority 13(43.33%) of them were between 41-50 years of age.  
 
Regarding sex in experimental group majority 24(80%) were females as well 
as in control group also females were majority 26(86.67%). 
 
Regarding education in the experimental group majority 21(70%) were 
uneducated as well as in control group also majority 20(66.67%) were uneducated. 
 
Regarding occupation in the experimental group majority 18(60%) were 
coolie as well as in control group also majority 12 (40%) were coolie. 
Regarding income in the experimental group majority 28(93.33%) were above 
24,000/- as well as in control group also majority 12 (40%) were above 24,000/-. 
Regarding marital status in the experimental group majority 29(96.67%) were 
married as well as in control group also majority 29(96.67%) were married. 
 
Regarding religion in the experimental group majority 27(90%) were Hindu as 
well as in control group also majority 25(83.33%) were Hindu. 
 
Regarding duration of illness in the experimental group majority 22(73.33%) 
were 6 months to 1 year as well as in control group also majority 22(73.33%) were 6 
months to 1 year. 
 
Regarding how long on chemotherapy in the experimental group majority 
17(56.66%) were 4 to 6 cycle as well as in control group also majority 20(66.66%) 
were 4 to 6 cycle. 
 
Regarding frequency of chemotherapy cycle in both experimental group and 
control group majority 29(96.66%) were 21 days cycle.  
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TABLE 2 DISTRIBUTION OF PATIENTS BASED ON PRE TEST LEVEL OF 
ADVERSE EFFECTS IN EXPERIMENTAL GROUP AND CONTROL 
GROUP 
N = 60 
Level of adverse 
effects 
Score 
Control group Experimental group 
f % f % 
Normal 
 
Mild 
 
Moderate 
 
Severe 
1-10 
 
11-20 
 
21-30 
 
31-40 
- 
 
- 
 
13 
 
17 
- 
 
- 
 
43.4% 
 
56.6% 
- 
 
1 
 
14 
 
15 
- 
 
3.4% 
 
46.6% 
 
50% 
 
Table 2 shows that among 30 before aromatherapy in the experimental group  
majority 15(50%) had severe adverse effects  and among 30 in the control group 
majority 17(56.6%) had severe adverse effects. 
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FIGURE 2 DISTRIBUTIONS OF PATIENTS BASED ON POST LEVEL OF ADVERSE EFFECTS   IN EXPERIMENTAL GROUP 
AND CONTROL GROUP 
 
 
Figure 2 shows that among 30 after aromatherapy in experimental group majority adverse effects reduced to moderate 14 and in the 
control group majority 21  had severe pain. 
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TABLE 3 EFFECTIVENESS OF AROMATHERAPY ON ADVERSE 
EFFECTS IN EXPERIMENTAL GROUP AND CONTROL GROUP 
N = 60 
Group 
Overall 
score 
Pretest Post test 
Mean 
difference 
Paired “T” 
test value 
Experimental 
group 
Mean  32 17.43 
14.57 13.00* 
SD 4.0144 4.66 
Control 
group 
Mean  33 32 
1 #1.29 
SD 3.08 2.898 
 
#not significant at P<0.05                                                    
*significant at P>0.05 
 df(29)=2.05 
Table 3-reveals regarding the effectiveness of aromatherapy on chemotherapy 
adverse effects, in the experimental group and control group. In the experimental 
group the obtained “t” value at 29 df is 13.00* was significant. 
 
Based on the study findings null hypothesis is rejected. It infers that the 
aromatherapy is effective in reducing adverse effects among patients undergoing 
chemotherapy.  
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TABLE 4 DIFFERENCES BETWEEN PRETEST LEVEL OF ADVERSE 
EFFECTS IN CONTROL GROUP AND EXPERIMENTAL GROUP  
N = 60 
Group 
Experimental group Control group “T” test 
value     Mean        SD Mean SD 
Experimental pre test 
and control pre test 
32 4.01 33 3.08 #1.08 
 
 
# Non significant at P<0.05 
*significant at P>0.05 
df(29)=2.05 
            Table 4 reveals regarding difference between pretest level of adverse effects  
in control group and experimental group obtained ‘t’ value 1.08  was not significant. 
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TABLE 5 DIFFERENCE BETWEEN POSTTEST LEVEL OF ADVERSE 
EFFECTS IN CONTROL GROUP AND EXPERIMENTAL GROUP  
N = 60 
Group 
Experimental group Control group “T” test 
Value      Mean SD Mean SD 
Experimental post test  
and control Post test 
17.43 4.66 32 2.898 14.51* 
 
# Non significant at P<0.05 
*significant at P>0.05 
df(29)=2.05 
         Table 5 revels regarding the difference between post test level of adverse effects 
in the experimental group  and control group  obtained ‘t’value at 29 df is 14.51* was  
significant. 
 
 It concluded that aromatherapy is effective in reducing in adverse effects of 
chemotherapy. 
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TABLE 6 ASSOCIATION BETWEEN THE ADVERSE EFFECTS WITH 
SELECTED DEMOGRAPHIC VARIABLES IN THE EXPERIMENTAL 
GROUP  
N = 30 
S. No Demographic Variables 
Adverse effects rating score χ2 
Normal mild Moderate severe 
1 
 
 
 
 
Age in years 
a)21-30 years 
b)31-40years 
c)41-50years  
d)above 50 years 
 
1 
1 
0 
1 
 
0 
6 
3 
5 
 
1 
4 
3 
6 
 
0 
0 
0 
0 
 
#8.207 
 
2 
 
 
Sex 
a)male 
b)female 
 
0 
2 
 
2 
22 
 
4 
0 
 
0 
0 
14.74* 
3 
 
 
 Education 
a)Educated 
b)Uneducated 
 
1 
1 
 
4 
10 
 
4 
10 
 
0 
0 
#0.8278 
4 
 
 
 
 
 
 
Occupation 
a)coolie 
b)private employee 
c)government employee 
d)business 
e)retired 
f)others 
 
1 
0 
0 
0 
0 
1 
 
8 
3 
1 
0 
0 
3 
 
9 
1 
0 
0 
0 
3 
 
0 
0 
0 
0 
0 
0 
 
 
 
26.44* 
 
 
 
 
5 
 
Income 
a)below 24,000/- 
b)above 24,000/- 
 
1 
1 
 
1 
13 
 
0 
14 
 
0 
0 
 
#3.5008 
 
6 
 
 
 
 
Marital status 
a)Married 
b)single 
c)divorce 
d)widow  
 
2 
0 
0 
0 
 
13 
0 
0 
1 
 
14 
0 
0 
0 
 
0 
0 
0 
0 
 
 
24.3481* 
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7 Religion 
a)Hindu 
b)Muslim 
c)Christian 
d)Others 
 
2 
0 
0 
0 
 
13 
1 
2 
0 
 
12 
0 
2 
0 
 
0 
0 
0 
0 
 
 
#8.7683 
 
8  Duration of illness 
a)below 6 months 
b)7 months -1year 
c)2 years-6years 
d)above 6 years 
 
1 
1 
0 
0 
 
2 
10 
2 
0 
 
0 
11 
1 
0 
 
0 
0 
0 
0 
 
 
 
#3.769 
 
9 How long on 
chemotherapy 
a)1 st  cycle 
b)2-3 cycle 
c)4-6 cycle 
d)above 6 cycle 
 
0 
1 
1 
0 
 
 
0 
6 
9 
0 
 
0 
5 
8 
0 
 
 
0 
0 
0 
0 
 
 
 
 
#4.754 
 
 
10 Frequency of 
chemotherapy cycle? 
a)15 days cycle 
b)21 days cycle 
c)30 days cycle 
 
 
0 
2 
0 
 
 
1 
14 
0 
 
 
0 
13 
0 
 
 
0 
0 
0 
 
 
13.724* 
 
The table 6 revels that obtained chi-square value #0.8278P<0.05 showed no 
significant association between education and adverse effects among patients 
undergoing chemotherapy. 
 
The obtained chi-square value # 8.768P<0.05 showed no significant 
association between religion and adverse effects among patients undergoing 
chemotherapy. 
 
The obtained chi-square value # 26.44P<0.05 showed highly significant 
association between occupation and adverse effects among patients undergoing 
chemotherapy. 
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The obtained chi-square value # 3.5008P<0.05 showed no significant 
association between income and adverse effects among patients undergoing 
chemotherapy. 
 
The obtained chi-square value *24.348P<0.05 showed significant association 
between marital status and adverse effects among patients undergoing chemotherapy. 
 
The obtained chi-square value # 3.769 P<0.05 showed no significant 
association between duration of illness and adverse effects among patients undergoing 
chemotherapy. 
 
The obtained chi-square value # 4.754P<0.05 showed no significant 
association between how long on chemotherapy and adverse effects among patients 
undergoing chemotherapy. 
 
The obtained chi-square value *13.724(P<0.05) showed significant association 
between frequency of chemotherapy cycle and adverse effects among patients 
undergoing chemotherapy. 
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CHAPTER-V 
DISCUSSION 
 
 This chapter deals with the discussion and interpretation of the findings to 
evaluate the effectiveness of aromatherapy in reducing adverse effects among patients 
undergoing chemotherapy. 
 
 The discussion was based on the objectives specified in this study. 
 The first objective of this study was to assess adverse effects of 
chemotherapy among the experimental group and control group before giving 
aromatherapy.  
 
 Among 30 in experimental group before aromatherapy the adverse effects of 
chemotherapy mean value was 32 and in the control group the adverse effects of 
chemotherapy mean value was 33. 
 
 The findings are supported with the study conducted by Lisa colodny et.al ,he 
concluded that nausea and vomiting are most common complaints of oncology 
patients who receive chemotherapeutic agents and  fatigue also is one of the most 
common complaints in chemotherapy .he recommended to assess and manage adverse 
effects to improve the quality of life of chemotherapy patients.  
 
 Based on the study finding the investigator suggests that the complete 
assessment refers to found the adverse effects of chemotherapy. 
 
 The second objective of this study was to assess the adverse effects of 
chemotherapy among the experimental group and control group after giving 
aromatherapy. 
 Among 30 in experimental group after aromatherapy the adverse effects mean 
value reduced to 17.43 and in the control group the level adverse effects of mean 
value was 33.   
 This  study supported by the Margaret et.al (2002),use of aromatherapy to 
decrease pain, depression, fatigue and to promote sense of well being to patients 
undergoing chemotherapy. Therefore the treatment of aromatherapy to be effective 
for in terminally ill cancer patients.    
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 From this study finding the investigator concludes that the aromatherapy is 
effective in reducing adverse effects among patients undergoing chemotherapy.  
 
 The third objective of this study to find out the effectiveness of 
aromatherapy on adverse effects among patients on chemotherapy. 
 
 After aromatherapy in the experimental group the adverse effects reduced to 
17.43where as in control group the mean value of adverse effects was 32.in the 
experimental group the obtained paired‘t’ value at df (29) is 14.51* which is 
significant. 
 
 The findings are supported with the study conducted by Annika Billhult et.al 
(2007),the getting aromatherapy during chemotherapy results revealed from negative 
to positive ,a sense of relaxation and finally they just felt good . 
 
 Obtained this study finding the investigator concludes that the aromatherapy is 
effective in reducing adverse effects among patients undergoing chemotherapy. 
 
 The fourth objective of this study was to find out the association between 
the adverse effects with selected demographic variables. 
 
 There was significant association between adverse effects of chemotherapy 
with selected demographic variables such as sex obtained chi-square value 14.74* 
marital status obtained chi-square value 24.3481* and occupation obtained chi-square 
value 26.44*. 
 
 The findings supported by the Nagal kamdi et.al (2010), he concluded that 
adverse effects associated with selected demographic variables. 
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CHAPTER-VI 
SUMMARY AND RECOMMENDATIONS 
 
The essence of any research project lies in the reporting of the findings. This 
chapter gives a brief account of the pre study ,along with the conclusion drawn from 
the findings , nursing implications, and recommendations for further studies. 
 
SUMMARY 
The focus of the study was to evaluate effectiveness of aromatherapy on 
selected adverse effects of chemotherapy .the quasi experimental design was adopted 
for the study .the study was conducted for a period of 6 weeks at selected cancer 
centre in Madurai. Based on the inclusion criteria 60 samples were selected 
purposively .Rating scale used for the assessment of chemotherapy adverse effects. 
The conceptual framework for the study was based on the Nursing process. 
descriptive and inferential statistics were used to report the findings.   
 
SUMMARY OF THE STUDY FINDINGS 
Regarding the level of adverse effects among in experimental group was 32 
and in the control group level of adverse effects was 33. 
 
Regarding after aromatherapy the level of adverse effects among experimental 
group was 17.43 and in the control group level of adverse effects was 32. 
 
After aromatherapy in the experimental group the mean value of level of 
adverse effects has reduced to 17.43 where as in the control group the mean value of 
adverse effects is 32 ,in the experimental group the obtained “t” value at df (29) is 
13.00*. 
 
Regarding the association between the level of adverse effects with the 
demographic variables in the experimental group there was significant between the 
sex and adverse effects of chemotherapy. 
 
Regarding the association between the marital status and adverse effects of 
chemotherapy. 
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Regarding the association between the frequency of chemotherapy cycle and 
adverse of chemotherapy. 
 
Regarding the association between the level of adverse effects with the 
demographic  variables  in  the  control  group  there  was  no significant between the 
demographic variables  and  adverse  effects  of  chemotherapy. 
 
CONCLUSION 
        The following conclusions were drawn from the study 
• The level of selected adverse effects were found to be higher in the control 
group and experimental group before aromatherapy  
• The level of selected adverse effects became slightly reduced in the 
experimental group and slight variation in the control group 
• The aromatherapy is effective in reducing selected adverse effects of 
chemotherapy patients. 
• There is significant association between the selected adverse effects with 
selected demographic variables in experimental group . 
• There is no significant association between the selected adverse effects with 
selected demographic variables in control group. 
 
More patients suffering with chemotherapy side effects .Aromatherapy is one 
of the non –pharmacological therapy  can be performed anywhere .It requires only 
aromatherapy lavender oil ,is non –invasive ,low cost of effective and do not 
compromise with patients privacy. Hence ,aromatherapy is provide to be one of the 
effective complementary therapies to relieve selected adverse effects and promote 
quality of life among patients undergoing chemotherapy.  
                                     
IMPLICATIONS 
The implications of the findings has been discussed in relation to nursing 
service, nursing education, nursing administration and nursing research. 
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Implications in Nursing Practice 
1. The result of the study can create awareness and motivate the nurses to 
practice aromatherapy as a technique of relaxation can use as an adjunct to 
pharmacological methods of chemotherapy adverse effects. 
2. Nurses can manage chemotherapy adverse effects in an economical and less 
time consuming way, which can reduce the need of pharmacological 
intervention. 
3. Nurses can improve communication and rapport with clients as aromatherapy 
combines the benefits of simple touch which conveys caring and nurturing. 
4. Nurses can teach the techniques of aromatherapy to the caregivers to extend 
the care even at home. 
Implications in Nursing Education 
1. The results of the study were used as informative illustration to students by 
their nursing teachers to adapt aromatherapy as a non- pharmacological 
intervention to reduce adverse effects of chemotherapy. 
2. It could help nursing students to plan and organize the nursing intervention to 
manage adverse effects of chemotherapy  effectively with complementary and 
alternative therapies. 
3. Periodic  conferences , seminars and symposium can be arranged regarding 
alternative and complementary therapies to make nursing professional 
competent to meet the ever changing needs of the society. 
 
Implications in Nursing Administration 
1. The nursing administrator should take more responsibility to implement  a  
protocol of aromatherapy/ complementary  therapies as a  relaxation technique 
for patient with chronic illness and adverse effects of chemotherapy . 
2. Administrator should motivate the staff for effective adverse effects of 
chemotherapy  management which should help in faster recovery, prevent 
complications  and there by provide cost effective care to their clients. 
3. The nursing administrator should organize in service education about 
complementary and alternative therapies and provide adequate  reading 
material to refresh their knowledge and get acquainted with newer techniques. 
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Implications in Nursing Research 
 The find of the study served as a basis for the nursing personnel on 
1. Increasing awareness on aromatherapy. 
2. The study can be published on journal to disseminate knowledge regarding 
non-pharmacological  intervention  for chemotherapy adverse effects  
perception and selected associated symptoms. 
3. The findings of the study served as a basis for the nursing professional and 
students to conduct further studies. 
 
RECOMMENDATIONS 
Chemotherapy adverse effects is one of the most common symptoms in clients 
with advanced cancer. It is certainly the most feared and cancer chemotherapy 
adverse effects continues to remain a significant problem for oncology patients. 
Hence effective management of cancer chemotherapy adverse effects is as important 
as the medical intervention of the disease itself. This warrants a holistic approach in 
nursing care. 
 
       The study recommends the following for further research  
1. A comparative study can be performed to evaluate the effectiveness of 
different complementary therapies like aromatherapy with guided imagery 
and / or music therapy. 
2. A similar study can be conducted as aromatherapy  intervention   to modify 
the  symptoms of  nausea, vomiting and in patients undergoing 
chemotherapy. 
3. A similar study can be conducted with case study approach on specific 
adverse effects of chemotherapy. 
4. Further research can be conducted  with the help of other chemotherapy 
adverse effects scales. 
 
 
 
 
 
